ServiceNow Showing Signs of Life But Still Down 25% YTD: 115% Returns Coming If This Analyst is Correct

Photo of Alex Sirois
By Alex Sirois Published

Quick Read

  • Bernstein's $248 Outperform target implies 114% upside for ServiceNow, dwarfing the 21% consensus gap with an overwhelmingly bullish analyst community.

  • NOW carries the widest implied upside among software peers, with CRM showing 28% upside to consensus while WDAY trades at essentially zero implied return.

  • ServiceNow AI surpassed $1B in annual contract value with agentic deployments up ninefold in nine months, anchoring the bull case for accelerating growth.

  • The most widely read finance newsletter on Substack isn't published by a bank, it's Doomberg, where 383,000+ readers get the energy and macro analysis the mainstream press misses. 24/7 Wall St. readers save 17% on their first year here.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
ServiceNow Showing Signs of Life But Still Down 25% YTD: 115% Returns Coming If This Analyst is Correct

© Donny Gonzo / Wikimedia Commons

ServiceNow (NYSE:NOW | NOW Price Prediction) currently trades at $115.76 while the average Wall Street price target sits at $140.25, a gap of roughly 21%.

ServiceNow runs the workflow platform Fortune 500 companies use to route IT tickets, HR requests, and autonomous AI agent tasks. The Street is watching because the company’s AI Control Tower positions ServiceNow as the governance layer for enterprise agentic AI, a spot investors want exposure to as the software sector debates AI disruption.

One shop thinks consensus is dramatically too conservative. Bernstein recently lifted its target from $236 to $248, an Outperform call that implies roughly 114% upside from here. That dispersion between the average and the high mark signals meaningful disagreement.

How ServiceNow Lost Nearly Half Its Value in a Year

NOW is down 41.72% over the past year. The 52-week range runs from a $81.24 low to a $196.40 high, with the 200-day moving average near $125.96, and shares still sit below the 200-day moving average.

The damage came from multiple forces: enterprise software repricing on generative AI fears, FX headwinds of $35 million to Q3 cRPO, government shutdown deal-timing risk, GAAP subscription gross margin sliding from 80% to 73.5% on intangibles amortization from acquisitions, and layoffs affecting roughly 3,000 workers globally.

Signs of life have appeared. Shares are up 21.27% in the past week and 15.79% over the past month following Q2 results that beat on both lines.

Why the Street Refuses to Blink

Analysts have not moved because operating metrics are accelerating. Q2 subscription revenue grew 24.5% to $3.88 billion, current RPO climbed 21% to $13.2 billion, and ServiceNow AI crossed $1 billion in annual contract value with agentic deployments up ninefold in nine months.

The Bernstein $248 thesis rests on two pillars: the Pro Plus tier embedding generative AI into workflows driving net-new ACV faster than standard SaaS seat expansion, and the AI Control Tower orchestrating heterogeneous IT stacks. Evercore ISI’s Kirk Materne set a more grounded $160 target, still comfortably above current levels.

CEO Bill McDermott framed the position bluntly: “ServiceNow’s exceptional Q2 results solidify our position as the fastest-growing major enterprise software and cybersecurity company, operating to the Rule of 56, well on our way to the Rule of 60.” The coverage skew is 9 Strong Buy, 34 Buy, 4 Hold, 1 Sell, 0 Strong Sell, with recent revisions tilting toward reiterations. Bernstein’s math assumes 2030 targets of $30 billion in subscription revenue and 30% of ACV from AI.

Where NOW Stacks Up Against CRM and WDAY

The peer group sold off together, but ServiceNow’s operating momentum has separated it from its closest competitors.

Salesforce (NYSE:CRM) is down 28.52% year to date and trades at $188.38 against a target of $241.72, implying roughly 28% upside. Ratings tilt Buy at 6 Strong Buy, 34 Buy, 10 Hold, 2 Strong Sell.

Workday (NASDAQ:WDAY) has fallen 21.78% year to date to $168.01, remarkably close to its $168.64 consensus target. Implied upside is essentially zero. Ratings split 6 Strong Buy, 19 Buy, 16 Hold, a materially more cautious posture.

The largest analyst-implied upside across the group belongs to ServiceNow, whether measured against the $140.25 consensus or Bernstein’s $248.

The 21% Consensus Gap by the Numbers

NOW trades at $115.76 against a consensus 12-month target of $140.25, a roughly 21% implied gap. Bernstein’s $248 represents a 114% dislocation, likely the widest single-analyst spread among mega-cap software names.

The coverage universe is dense: 48 analyst ratings, with 43 in Buy or Strong Buy. NOW carries a P/E of 66 trailing and 26 forward, reflecting the growth premium despite the drawdown.

NOW is down 24.43% year to date while the S&P 500 has returned 6.97%. The 31-point spread against the index captures the setup.

Buy the Recovery or Wait for Proof

The bull case for ServiceNow rests on believing agentic AI monetization is real and that the Pro Plus tier delivers the 20% to 30% pricing uplift management laid out. The path back to $140 requires holding 20%-plus subscription growth into 2027 while operating margins stay above 30%. Bernstein’s $248 needs more: AI ACV compounding toward 30% of mix and the Control Tower cementing as the enterprise governance standard.

The bear case argues seat-based software is structurally impaired by AI agents replacing users, that acquisition integration costs continue compressing operating income (which fell 54.75% year over year in Q2), and that Q3’s deceleration from the Federal pull-forward gives skeptics fresh ammunition.

The setup skews constructive. A dense Buy skew with almost no Sell coverage, four consecutive EPS beats, and demonstrable AI revenue traction is a hard combination to fade. The 21% consensus gap looks defensible. Bernstein’s 114% call is a stretch worth watching.

Contact [email protected] for any questions or corrections.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Continue Reading

Top Gaining Stocks

MRNA Vol: 120,899,086
EL Vol: 8,069,441
COIN Vol: 8,979,479
MRK Vol: 20,612,776
JKHY Vol: 894,347

Top Losing Stocks

CTRA Vol: 73,319,495
KEYS Vol: 1,909,961
CRWD Vol: 5,813,493
LRCX Vol: 4,635,332
STX Vol: 2,785,292